Showing results (1621-1630 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|September 28, 2021
Clinical Significance and Underlying Mechanisms of CELSR3 in Metastatic Prostate Cancer Based on Immunohistochemistry, Data Mining, and In Silico AnalysisYu Sun, Gang Chen, Juan He, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
A Clinical Study on Microwave Ablation in Combination with Chemotherapy in Treating Peripheral IIIB-IV Non-Small Cell Lung CancerYing-Qing Zhang, Yong-Lei Wu, Yan Feng, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Gene Silencing of Transcription Factor TEAD4 Inhibits Esophageal Cancer Cells by Regulating TCF7Songlin He, Ke Gao, Long Mao, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Preclinical PET Imaging of NTSR-1-Positive Tumors with 64Cu- and 68Ga-DOTA-Neurotensin Analogs and Therapy with an 225Ac-DOTA-Neurotensin AnalogDaneng Li, Megan Minnix, Rebecca Allen, et al.Cancer Biotherapy & Radiopharmaceuticals|August 25, 2020
Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT PathwayHongqian Yin, Xia CuiCancer Biotherapy & Radiopharmaceuticals|August 25, 2020
Long Noncoding RNA NEAT1 Promotes the Progression of Breast Cancer by Regulating miR-138-5p/ZFX AxisLige Yao, Lu Chen, Hanli Zhou, et al.Cancer Biotherapy & Radiopharmaceuticals|August 25, 2020
Effect of Oral Nutritional Supplements on Patients with Esophageal Cancer During RadiotherapyLiping Yang, Jing Gao, Yan Zhou, et al.Cancer Biotherapy & Radiopharmaceuticals|August 21, 2020
High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling PathwayQin Liu, Chun-Yan Chen, Gui-Lin ChenCancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Strategic Clinical Trial Design for Boron Neutron Capture TherapyAndrea Wittig, Wolfgang A G SauerweinCancer Biotherapy & Radiopharmaceuticals|August 18, 2020
GAS6-AS2 Promotes Hepatocellular Carcinoma via miR-3619-5p/ARL2 Axis Under Insufficient Radiofrequency Ablation ConditionZilin Li, Manhong Jiang, Ting Zhang, et al.Pageof 224